Browse Category

Market Forecasts News 23 December 2025 - 24 December 2025

Applied Materials Stock (AMAT) After Hours on Dec. 23, 2025: Latest Move, Today’s Forecasts, and What to Watch Before the Market Opens Wednesday

Applied Materials Stock (AMAT) After Hours on Dec. 23, 2025: Latest Move, Today’s Forecasts, and What to Watch Before the Market Opens Wednesday

Applied Materials, Inc. (NASDAQ: AMAT) is heading into the Christmas Eve session with a quiet after-hours tape—but plenty of cross-currents underneath. After Tuesday’s regular session, AMAT hovered slightly higher in extended trading, while investors continued to weigh a familiar mix:
BitMine Immersion Technologies (BMNR) Stock After Hours Dec. 23, 2025: Latest News, Price Targets, and What to Watch Before the Dec. 24 Market Open

BitMine Immersion Technologies (BMNR) Stock After Hours Dec. 23, 2025: Latest News, Price Targets, and What to Watch Before the Dec. 24 Market Open

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) ended regular trading on Tuesday, December 23, 2025 at $29.78 and slipped to $29.64 in after-hours trading (as of 7:31 p.m. ET), capping a volatile session that saw the stock trade as low
UnitedHealth Group (UNH) Stock After Hours Today (23.12.2025): Latest News, Forecasts, and What to Watch Before the Market Opens Tomorrow

UnitedHealth Group (UNH) Stock After Hours Today (23.12.2025): Latest News, Forecasts, and What to Watch Before the Market Opens Tomorrow

UnitedHealth Group Incorporated (NYSE: UNH) finished Tuesday, December 23, 2025 (23.12.2025) near the $325 level and traded modestly higher in after-hours, as investors head into a holiday-shortened Christmas Eve session with a heavy macro and policy calendar—but no major new
UiPath Stock (PATH) Slides on Dec. 23, 2025: Today’s Move, Analyst Forecasts, and What Matters Next for 2026

UiPath Stock (PATH) Slides on Dec. 23, 2025: Today’s Move, Analyst Forecasts, and What Matters Next for 2026

UiPath Inc. (NYSE: PATH) is having one of those “welcome to equities” days: after a strong run in December, the automation software company’s shares pulled back sharply in Tuesday trading, even as the broader investment narrative around agentic automation and
Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

Kenvue Inc. (NYSE: KVUE) is trading in a very particular kind of gravity field on December 23, 2025: part consumer-health staple, part legal-headline lightning rod, and—most importantly right now—part merger-arbitrage instrument because of its pending acquisition by Kimberly-Clark. As of
Micron Technology (MU) Stock on Dec. 23, 2025: AI Memory Crunch, Blowout Guidance, and Fresh Wall Street Price Targets

Micron Technology (MU) Stock on Dec. 23, 2025: AI Memory Crunch, Blowout Guidance, and Fresh Wall Street Price Targets

Micron Technology, Inc. (NASDAQ: MU) is closing out 2025 in the spotlight as investors price in what many analysts are calling a new phase for the historically cyclical memory market—one increasingly tied to AI data-center buildouts, high-bandwidth memory (HBM) supply
Meta Platforms (META) Stock News, Forecasts and Analysis for December 23, 2025: AI Capex, Analyst Targets, and the 2026 Debate

Meta Platforms (META) Stock News, Forecasts and Analysis for December 23, 2025: AI Capex, Analyst Targets, and the 2026 Debate

Meta Platforms, Inc. (NASDAQ: META) stock is heading into the final stretch of 2025 with a familiar tug-of-war: strong advertising momentum and new AI-driven product bets on one side, and intensifying infrastructure spending (and the accounting, regulatory, and legal scrutiny
Eli Lilly Stock (LLY) Outlook on Dec. 23, 2025: Novo’s Wegovy Pill, Lilly’s Next Catalysts, and Wall Street Forecasts

Eli Lilly Stock (LLY) Outlook on Dec. 23, 2025: Novo’s Wegovy Pill, Lilly’s Next Catalysts, and Wall Street Forecasts

December 23, 2025 — Eli Lilly and Company (NYSE: LLY) is trading around $1,076 as investors digest a fresh competitive jolt in the obesity-drug race: the FDA has approved Novo Nordisk’s first daily oral version of Wegovy. The headline is
Cemtrex (CETX) Stock News Today: Acquisition Timeline, Dilution Signals, and Fresh Forecasts as Shares Swing Into Dec. 23, 2025

Cemtrex (CETX) Stock News Today: Acquisition Timeline, Dilution Signals, and Fresh Forecasts as Shares Swing Into Dec. 23, 2025

December 23, 2025 — Cemtrex, Inc. (NASDAQ: CETX) is ending the year the way micro-caps often do: loudly. After a sharp, high-volume jump in the latest session, traders are now weighing a cluster of late-2025 catalysts—most notably a near-term aerospace-and-defense
1 2 3 29
Go toTop